Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_assertion type Assertion NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_head.
- NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_assertion description "[It should be concluded that DRB1*13, which showed a decrease in patients, should be protective against acute lymphoblastic leukemia (ALL), whereas DRB1*04, which was moderately increased in patients, could be considered a susceptible allele for childhood ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_provenance.
- NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_assertion evidence source_evidence_literature NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_provenance.
- NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_assertion SIO_000772 18164964 NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_provenance.
- NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_assertion wasDerivedFrom befree-20150227 NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_provenance.
- NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_assertion wasGeneratedBy ECO_0000203 NP455026.RACtBVB-5LHQFX4vBj4hKz2x5jD3GLM0DtYWPKoYSW-94130_provenance.